Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 03-2021 | |
| Cash Flows From Operating Activities | ||
| Accounts receivable | -29 | -25 |
| Other Working Capital | 205 | -134 |
| Other Operating Activity | -723 | -71 |
| Operating Cash Flow | $-547 | $-230 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $0 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,403 | 360 |
| Other Financing Activity | 1,225 | 0 |
| Financing Cash Flow | $2,628 | $360 |
| Exchange Rate Effect | 0 | -4 |
| Beginning Cash Position | 133 | 2 |
| End Cash Position | 2,214 | 128 |
| Net Cash Flow | $2,081 | $130 |
| Free Cash Flow | ||
| Operating Cash Flow | -547 | -230 |
| Free Cash Flow | -547 | -230 |